This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 Jul 5;296(1):94-5.

doi: 10.1001/jama.296.1.94.

Varenicline for smoking cessation: definite promise, but no panacea

Robert C Klesges, Karen C Johnson, Grant Somes

PMID: 16820552
DOI: 10.1001/jama.296.1.94

Editorial

Varenicline for smoking cessation: definite promise, but no panacea

Robert C Klesges et al. JAMA. 2006.

. 2006 Jul 5;296(1):94-5.

doi: 10.1001/jama.296.1.94.

Authors

Robert C Klesges, Karen C Johnson, Grant Somes

PMID: 16820552
DOI: 10.1001/jama.296.1.94

No abstract available

PubMed Disclaimer

Comment on

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group. Gonzales D, et al. JAMA. 2006 Jul 5;296(1):47-55. doi: 10.1001/jama.296.1.47. JAMA. 2006. PMID: 16820546 Clinical Trial.
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group. Jorenby DE, et al. JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56. JAMA. 2006. PMID: 16820547 Clinical Trial.
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; Varenicline Phase 3 Study Group. Tonstad S, et al. JAMA. 2006 Jul 5;296(1):64-71. doi: 10.1001/jama.296.1.64. JAMA. 2006. PMID: 16820548 Clinical Trial.

Similar articles

[Drug of the month. Varenicline (Champix)].
Vandemergel X. Vandemergel X. Rev Med Liege. 2007 Feb;62(2):122-4. Rev Med Liege. 2007. PMID: 17461303 French.
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group. Jorenby DE, et al. JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56. JAMA. 2006. PMID: 16820547 Clinical Trial.
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group. Gonzales D, et al. JAMA. 2006 Jul 5;296(1):47-55. doi: 10.1001/jama.296.1.47. JAMA. 2006. PMID: 16820546 Clinical Trial.
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA. Doggrell SA. Expert Opin Pharmacother. 2007 Dec;8(17):2903-15. doi: 10.1517/14656566.8.17.2903. Expert Opin Pharmacother. 2007. PMID: 18001252 Review.
Non-nicotinic therapies for smoking cessation.
Siu EC, Tyndale RF. Siu EC, et al. Annu Rev Pharmacol Toxicol. 2007;47:541-64. doi: 10.1146/annurev.pharmtox.47.120505.105354. Annu Rev Pharmacol Toxicol. 2007. PMID: 17209799 Review.

See all similar articles

Cited by

Varenicline: A review of the literature and place in therapy.
Whitley HP, Moorman KL. Whitley HP, et al. Pharm Pract (Granada). 2007 Apr;5(2):51-8. doi: 10.4321/s1886-36552007000200001. Pharm Pract (Granada). 2007. PMID: 25247008 Free PMC article.
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
Wu P, Wilson K, Dimoulas P, Mills EJ. Wu P, et al. BMC Public Health. 2006 Dec 11;6:300. doi: 10.1186/1471-2458-6-300. BMC Public Health. 2006. PMID: 17156479 Free PMC article.
Varenicline: a review of its use as an aid to smoking cessation therapy.
Keating GM, Siddiqui MA. Keating GM, et al. CNS Drugs. 2006;20(11):945-60. doi: 10.2165/00023210-200620110-00007. CNS Drugs. 2006. PMID: 17044731 Review.
Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
Zhu SH, Cummins SE, Gamst AC, Wong S, Ikeda T. Zhu SH, et al. Tob Control. 2016 Jul;25(4):464-9. doi: 10.1136/tobaccocontrol-2015-052332. Epub 2015 Aug 17. Tob Control. 2016. PMID: 26283713 Free PMC article.
Pharmacological intervention of nicotine dependence.
Jain R, Majumder P, Gupta T. Jain R, et al. Biomed Res Int. 2013;2013:278392. doi: 10.1155/2013/278392. Epub 2013 Dec 29. Biomed Res Int. 2013. PMID: 24490153 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information